Literature DB >> 20713622

LT-IIc, a new member of the type II heat-labile enterotoxin family encoded by an Escherichia coli strain obtained from a nonmammalian host.

Hesham F Nawar1, Natalie D King-Lyons, John C Hu, Raymond C Pasek, Terry D Connell.   

Abstract

Two families of bacterial heat-labile enterotoxins (HLTs) have been described: the type I HLTs are comprised of cholera toxin (CT) of Vibrio cholerae, LT-I of Escherichia coli, and several related HLTs; the type II HLTs are comprised of LT-IIa and LT-IIb. Herein, we report LT-IIc, a new type II HLT encoded from an enterotoxigenic E. coli (ETEC) strain isolated from an avian host. Using a mouse Y1 adrenal cell bioassay, LT-IIc was shown to be less cytotoxic than CT, LT-IIa, or LT-IIb. Cytotoxicity of LT-IIc was partially neutralized by antisera recognizing LT-IIa or LT-IIb but not by anti-CT antiserum. Genes encoding putative A polypeptide and B polypeptides of LT-IIc were arranged in an operon which was flanked by potential prophage sequences. Analysis of the nucleotide and predicted amino acid sequences demonstrated that the A polypeptide of LT-IIc has moderate homology to the A polypeptides of CT and LT-I and high homology to the A polypeptides of LT-IIa and LT-IIb. The B polypeptide of LT-IIc exhibited no significant homology to the B polypeptides of CT and LT-I and only moderate homology to the B polypeptides of LT-IIa and LT-IIb. The binding pattern of LT-IIc for gangliosides was distinctive from that of either LT-IIa or LT-IIb. The data suggest that other types of the type II HLT subfamily are circulating in the environment and that host specificity of type II HLT is likely governed by changes in the B polypeptide which mediate binding to receptors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20713622      PMCID: PMC2976314          DOI: 10.1128/IAI.00730-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

Review 1.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

2.  A second generation of double mutant cholera toxin adjuvants: enhanced immunity without intracellular trafficking.

Authors:  Yukari Hagiwara; Yuki I Kawamura; Kosuke Kataoka; Bibi Rahima; Raymond J Jackson; Katsuhiro Komase; Taeko Dohi; Prosper N Boyaka; Yoshifumi Takeda; Hiroshi Kiyono; Jerry R McGhee; Kohtaro Fujihashi
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

Review 3.  Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention.

Authors:  Firdausi Qadri; Ann-Mari Svennerholm; A S G Faruque; R Bradley Sack
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

4.  Detection of enterotoxigenic Escherichia coli in stool samples by using nonradioactively labeled oligonucleotide DNA probes and PCR.

Authors:  C Schultsz; G J Pool; R van Ketel; B de Wever; P Speelman; J Dankert
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

5.  Binding to gangliosides containing N-acetylneuraminic acid is sufficient to mediate the immunomodulatory properties of the nontoxic mucosal adjuvant LT-IIb(T13I).

Authors:  Hesham F Nawar; Charles S Berenson; George Hajishengallis; Hiromu Takematsu; Lorrie Mandell; Ragina L Clare; Terry D Connell
Journal:  Clin Vaccine Immunol       Date:  2010-04-14

6.  Molecular genetic analysis of ganglioside GD1b-binding activity of Escherichia coli type IIa heat-labile enterotoxin by use of random and site-directed mutagenesis.

Authors:  T D Connell; R K Holmes
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

7.  Variation in chemical properties and antigenic determinants among type II heat-labile enterotoxins of Escherichia coli.

Authors:  B E Guth; E M Twiddy; L R Trabulsi; R K Holmes
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

8.  The Type II heat-labile enterotoxins LT-IIa and LT-IIb and their respective B pentamers differentially induce and regulate cytokine production in human monocytic cells.

Authors:  George Hajishengallis; Hesham Nawar; Richard I Tapping; Michael W Russell; Terry D Connell
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

9.  Mutational analysis of the ganglioside-binding activity of the type II Escherichia coli heat-labile enterotoxin LT-IIb.

Authors:  T D Connell; R K Holmes
Journal:  Mol Microbiol       Date:  1995-04       Impact factor: 3.501

10.  Cloning of genes that encode a new heat-labile enterotoxin of Escherichia coli.

Authors:  C L Pickett; E M Twiddy; B W Belisle; R K Holmes
Journal:  J Bacteriol       Date:  1986-02       Impact factor: 3.490

View more
  15 in total

1.  TLR2-dependent modulation of dendritic cells by LT-IIa-B5, a novel mucosal adjuvant derived from a type II heat-labile enterotoxin.

Authors:  Chang Hoon Lee; Patricia Masso-Welch; George Hajishengallis; Terry D Connell
Journal:  J Leukoc Biol       Date:  2011-07-26       Impact factor: 4.962

2.  Characterization of the ganglioside recognition profile of Escherichia coli heat-labile enterotoxin LT-IIc.

Authors:  Dani Zalem; Martin Juhás; Manuela Terrinoni; Natalie King-Lyons; Michael Lebens; Annabelle Varrot; Terry D Connell; Susann Teneberg
Journal:  Glycobiology       Date:  2022-04-21       Impact factor: 5.954

Review 3.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 4.  Type II heat-labile enterotoxins: structure, function, and immunomodulatory properties.

Authors:  George Hajishengallis; Terry D Connell
Journal:  Vet Immunol Immunopathol       Date:  2012-09-26       Impact factor: 2.046

5.  LT-IIc, a new member of the type II heat-labile enterotoxin family, exhibits potent immunomodulatory properties that are different from those induced by LT-IIa or LT-IIb.

Authors:  Hesham F Nawar; Christopher J Greene; Chang Hoon Lee; Lorrie M Mandell; George Hajishengallis; Terry D Connell
Journal:  Vaccine       Date:  2010-11-21       Impact factor: 3.641

6.  Distinctive immunomodulatory and inflammatory properties of the Escherichia coli type II heat-labile enterotoxin LT-IIa and its B pentamer following intradermal administration.

Authors:  Camila Mathias-Santos; Juliana F Rodrigues; Maria Elisabete Sbrogio-Almeida; Terry D Connell; Luís C S Ferreira
Journal:  Clin Vaccine Immunol       Date:  2011-06-15

7.  Intradermal administration of the Type II heat-labile enterotoxins LT-IIb and LT-IIc of enterotoxigenic Escherichia coli enhances humoral and CD8+ T cell immunity to a co-administered antigen.

Authors:  John C Hu; Camila Mathias-Santos; Christopher J Greene; Natalie D King-Lyons; Juliana F Rodrigues; George Hajishengallis; Luís C S Ferreira; Terry D Connell
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

8.  Ganglioside-binding specificities of E. coli enterotoxin LT-IIc: Importance of long-chain fatty acyl ceramide.

Authors:  Charles S Berenson; Hesham F Nawar; Ragina L Kruzel; Lorrie M Mandell; Terry D Connell
Journal:  Glycobiology       Date:  2012-08-22       Impact factor: 4.313

9.  Type II heat-labile enterotoxins from 50 diverse Escherichia coli isolates belong almost exclusively to the LT-IIc family and may be prophage encoded.

Authors:  Michael G Jobling; Randall K Holmes
Journal:  PLoS One       Date:  2012-01-05       Impact factor: 3.240

10.  The Divergent CD8+ T Cell Adjuvant Properties of LT-IIb and LT-IIc, Two Type II Heat-Labile Enterotoxins, Are Conferred by Their Ganglioside-Binding B Subunits.

Authors:  John C Hu; Christopher J Greene; Natalie D King-Lyons; Terry D Connell
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.